share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Nov 19 16:05

Gainers

  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock moved upwards by 26.4% to $3.26 during Tuesday's pre-market session. The company's market cap stands at $4.3 million.
  • Aclaris Therapeutics (NASDAQ:ACRS) shares increased by 19.1% to $3.74. The company's market cap stands at $267.1 million.
  • Alumis (NASDAQ:ALMS) shares rose 15.74% to $10.0. The market value of their outstanding shares is at $544.0 million. The company's, Q3 earnings came out 4 days ago.
  • TFF Pharmaceuticals (NASDAQ:TFFP) shares rose 15.41% to $0.42. The company's market cap stands at $1.4 million.
  • HCW Biologics (NASDAQ:HCWB) shares increased by 15.32% to $1.43. The company's market cap stands at $54.0 million. As per the press release, Q3 earnings came out 3 days ago.
  • Fresh2 Group (NASDAQ:FRES) stock rose 14.36% to $1.1. The company's market cap stands at $26.9 million.

Losers

  • Apollomics (NASDAQ:APLM) stock fell 16.3% to $0.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $17.8 million.
  • Incyte (NASDAQ:INCY) stock fell 12.31% to $67.5. The market value of their outstanding shares is at $13.0 billion.
  • Cytek Biosciences (NASDAQ:CTKB) stock declined by 10.78% to $5.38. The market value of their outstanding shares is at $693.0 million.
  • Grifols (NASDAQ:GRFS) shares fell 10.42% to $8.26. The company's market cap stands at $5.6 billion.
  • GlucoTrack (NASDAQ:GCTK) shares decreased by 9.8% to $0.26. The company's market cap stands at $1.4 million. As per the press release, Q3 earnings came out 3 days ago.
  • Alkermes (NASDAQ:ALKS) stock decreased by 9.26% to $25.0. The company's market cap stands at $4.0 billion.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment